From January 1, 2024 to March 31, 2024, the company has repurchased 729,679 shares, representing 0.99% for $266.97 million. With this, the company has completed the repurchase of 1,995,340 shares, representing 2.7% for $705.31 million under the buyback announced on February 16, 2023.
West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
355.6 USD | +0.43% | -2.35% | +1.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.00% | 25.91B | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
-1.25% | 24.72B |
- Stock Market
- Equities
- WST Stock
- News West Pharmaceutical Services, Inc.
- Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.